Relations (1)
related 2.00 — strongly supporting 3 facts
Depression and neuroplasticity are linked as serotonergic psychedelics are proposed to treat depression by leveraging neuroplasticity [1], while chronic stress-induced depression is associated with reduced neuroplasticity in dopaminergic neurons [2]. Furthermore, research indicates that serotonin levels influence both the vulnerability to depression and the capacity for neuroplastic recovery [3].
Facts (3)
Sources
Integrating allostasis and emerging technologies to study complex ... nature.com 1 fact
accountCavalleri et al. modeled chronic stress and depression by exposing iPSC-derived dopaminergic neurons to high cortisol levels, observing structural changes and reduced neuroplasticity.
Psychedelics, Sociality, and Human Evolution frontiersin.org 1 fact
claimI. Branchi described neural plasticity as a double-edged sword, noting that increasing serotonin levels leads to both greater vulnerability to depression and an improved capacity to recover, in a 2011 study.
Neuroimaging in psychedelic drug development: past, present, and ... nature.com 1 fact
claimSerotonergic psychedelics may treat depression through the mechanism of neuroplasticity.